	Ebitda		日付
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Adma Biologics	USD 73.59M	14.85M	2025-12
ALKERMES	USD 100.31M	21.24M	2025-12
Alterity Therapeutics Limited	AUD -7.72M	2.99M	2023-06
AstraZeneca	USD 5.67B	1.29B	2026-03
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Bristol-Myers Squibb	USD 2.88B	1.36B	2025-12
Cipla	INR 12.55B	6.4B	2025-12
Clal Biotechnology	ILS -5.3M	2.09M	2022-12
Compugen	USD -7.89M	536K	2025-09
CSL	USD 3.13B	1.17B	2025-12
Eli Lilly	USD 12.14B	4.26B	2025-12
Esperion Therapeutics	USD -9.93M	24.99M	2025-09
GlaxoSmithKline	GBP 2.77B	1.65B	2026-03
Grifols	EUR 482.04M	7.04M	2025-09
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Ionis Pharmaceuticals	USD -200.02M	42.89M	2025-12
J&J	USD 7.19B	2.32B	2025-12
Merck	USD 6.3B	2.09B	2025-12
Minerva Neurosciences	USD -4.36M	1.71M	2024-09
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
Novartis	USD 5.3B	530M	2026-03
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 756M	5.32B	2025-12
Roche Holding	CHF 12.68B	2.36B	2024-06
Sanofi	EUR 3.31B	3.65B	2026-03
Takeda	JPY 448.13B	173.98B	2025-12
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12